Hiroo Maeda

1.2k total citations
53 papers, 827 citations indexed

About

Hiroo Maeda is a scholar working on Immunology, Epidemiology and Hematology. According to data from OpenAlex, Hiroo Maeda has authored 53 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 15 papers in Epidemiology and 12 papers in Hematology. Recurrent topics in Hiroo Maeda's work include Cervical Cancer and HPV Research (8 papers), Blood transfusion and management (7 papers) and T-cell and B-cell Immunology (7 papers). Hiroo Maeda is often cited by papers focused on Cervical Cancer and HPV Research (8 papers), Blood transfusion and management (7 papers) and T-cell and B-cell Immunology (7 papers). Hiroo Maeda collaborates with scholars based in Japan, Nigeria and United States. Hiroo Maeda's co-authors include Ranko Hirata, Toshiharu Yasugi, Koji Matsumoto, Mitsuo Okubo, Yukihiko Sugiyama, Akinori Oki, Yasuo Hirai, Naoyoshi Takatsuka, Akira Mitsuhashi and Nobuo Yaegashi and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Hiroo Maeda

52 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroo Maeda Japan 17 303 284 135 133 90 53 827
Susumu Nishinarita Japan 15 334 1.1× 107 0.4× 86 0.6× 41 0.3× 57 0.6× 66 695
Pauline Mackintosh United Kingdom 16 270 0.9× 201 0.7× 87 0.6× 114 0.9× 33 0.4× 35 789
Nobuhito Kashiwagi Japan 13 483 1.6× 337 1.2× 124 0.9× 72 0.5× 22 0.2× 26 889
Hanan Gur Israel 17 541 1.8× 204 0.7× 58 0.4× 139 1.0× 149 1.7× 35 1.2k
Marina Deschamps France 17 445 1.5× 136 0.5× 109 0.8× 101 0.8× 108 1.2× 39 968
A. Bratlie Norway 14 400 1.3× 74 0.3× 109 0.8× 86 0.6× 128 1.4× 36 744
M Jeannet Switzerland 20 534 1.8× 76 0.3× 438 3.2× 165 1.2× 74 0.8× 68 1.2k
V. Joysey United Kingdom 16 365 1.2× 85 0.3× 216 1.6× 236 1.8× 85 0.9× 33 809
Y Lebranchu France 10 116 0.4× 429 1.5× 80 0.6× 101 0.8× 35 0.4× 39 790
H. Noreen United States 22 748 2.5× 148 0.5× 306 2.3× 332 2.5× 71 0.8× 49 1.4k

Countries citing papers authored by Hiroo Maeda

Since Specialization
Citations

This map shows the geographic impact of Hiroo Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroo Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroo Maeda more than expected).

Fields of papers citing papers by Hiroo Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroo Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroo Maeda. The network helps show where Hiroo Maeda may publish in the future.

Co-authorship network of co-authors of Hiroo Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroo Maeda. A scholar is included among the top collaborators of Hiroo Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroo Maeda. Hiroo Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsunaga, Shigetaka, Yasushi Takai, Eishin Nakamura, et al.. (2017). The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia. Scientific Reports. 7(1). 46749–46749. 32 indexed citations
2.
Okubo, Mitsuo, et al.. (2013). FIBRINOGEN LEVELS AND BLOOD TRANSFUSION VOLUMES IN PATIENTS REQUIRING MASSIVE TRANSFUSION. Japanese Journal of Transfusion and Cell Therapy. 59(1). 38–42. 1 indexed citations
3.
Matsumoto, Koji, Hiroo Maeda, Akinori Oki, et al.. (2012). HLA Class II DRB1 *1302 Allele Protects Against Progression to Cervical Intraepithelial Neoplasia Grade 3. International Journal of Gynecological Cancer. 22(3). 471–478. 18 indexed citations
4.
Matsumoto, Koji, Akinori Oki, Reiko Furuta, et al.. (2010). Tobacco smoking and regression of low‐grade cervical abnormalities. Cancer Science. 101(9). 2065–2073. 38 indexed citations
5.
Okubo, Mitsuo, Maki Saito, Ranko Hirata, et al.. (2004). Analysis of HLA‐DRB1*0901‐binding HPV‐16 E7 helper T cell epitope†. Journal of obstetrics and gynaecology research. 30(2). 120–129. 5 indexed citations
6.
Matsumoto, Koji, Toshiharu Yasugi, Shunsuke Nakagawa, et al.. (2003). Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. International Journal of Cancer. 106(6). 919–922. 52 indexed citations
7.
Saito, Satoshi, Satoshi Ota, Toshihiro Ito, et al.. (2002). Platelet transfusion refractoriness caused by a mismatch in HLA‐C antigens. Transfusion. 42(3). 302–308. 33 indexed citations
8.
Fuji, Takeshi, et al.. (2000). A survey of autologous blood collection and transfusion in Japan in 1997. Transfusion Science. 22(1-2). 13–18. 13 indexed citations
9.
Ohto, Hitoshi, Hiroyasu Yasuda, Hiroo Maeda, & Shoichi Inaba. (2000). Post-transfusion thrombocytopenia in recipients with anti-HLA antibody. Transfusion Science. 23(3). 271–273. 2 indexed citations
10.
Salle, Henri de la, Jacques Zimmer, Dominique Fricker, et al.. (1999). HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. Journal of Clinical Investigation. 103(5). R9–R13. 97 indexed citations
11.
Ohto, Hitoshi, et al.. (1998). Report on informed consent in blood transfusions. Transfusion Science. 19(3). 201–215. 2 indexed citations
12.
Maeda, Hiroo. (1997). Blood Transfusion and Immunomodulation.. Journal of the Japan Society of Blood Transfusion. 43(6). 853–861. 3 indexed citations
13.
Duran, Karen, et al.. (1997). Two newly identified HLA-DRB1 alleles: DRB1 * 1322 and DRB1 * 1327. Immunogenetics. 46(5). 442–443. 2 indexed citations
14.
Islam, S. M. Monowarul, Jiro Numaga, Yujiro Fujino, et al.. (1995). Hla–dr8 and acute anterior uveitis in ankylosing spondylitis. Arthritis & Rheumatism. 38(4). 547–550. 45 indexed citations
15.
Takeda, Satoru, et al.. (1994). Autologous Blood Transfusion for the Patient with Placenta Previa Complicated by Placenta Increta: A Case Report. Asia-Oceania Journal of Obstetrics and Gynaecology. 20(2). 155–159. 2 indexed citations
16.
Koyama, Norihisa, Toshihiko Nakamura, Taihei Tanaka, et al.. (1991). Association of Neonatal Thrombocytopenia and Maternal Anti‐HLA Antibodies. Pediatrics International. 33(1). 71–76. 17 indexed citations
17.
Takeuchi, Fujio, Akio Mimori, Kunio Matsuta, et al.. (1989). Association of complement alleles c4aq0 and c4b5 with rheumatoid arthritis in japanese patients. Arthritis & Rheumatism. 32(6). 691–698. 7 indexed citations
18.
Suda, Junko, Mitsuoki Eguchi, Yasuhide Hayashi, et al.. (1988). Platelet peroxidase‐positive blast cells in transient myeloproliferative disorder with Down's syndrome. British Journal of Haematology. 68(2). 181–187. 21 indexed citations
19.
Matsuki, Kazumasa, Hiroo Maeda, Takeo Juji, et al.. (1988). Taq I-generated HLA-DQ ?polymorphism in Japanese patients with narcolepsy. Immunogenetics. 27(2). 87–90. 11 indexed citations
20.
Ohta, Ken, Kazuo Akiyama, Hirokazu Okudaira, et al.. (1980). Human IgE, IgG and IgE Antibody Synthesis <i>in vitro</i>. International Archives of Allergy and Immunology. 63(2). 129–138. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susumu Nishinarita Breakdown of academic impact, for papers by Pauline Mackintosh Breakdown of academic impact, for papers by Nobuhito Kashiwagi Breakdown of academic impact, for papers by Hanan Gur Breakdown of academic impact, for papers by Marina Deschamps Breakdown of academic impact, for papers by A. Bratlie Breakdown of academic impact, for papers by M Jeannet Breakdown of academic impact, for papers by V. Joysey Breakdown of academic impact, for papers by Y Lebranchu Breakdown of academic impact, for papers by H. Noreen
Rankless by CCL
2026